Agomab Therapeutics NV - AGMB

Sector: Healthcare · Industry: Biotechnology
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$334.3M
QoQ value delta ($000)
-$2.639M (-0.78%)
Implied price effect (QoQ)
-0.87%
Shares
Total shares
25,978,630
QoQ shares delta
+23,148 (+0.09%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (AGMB)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 4 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
EQT Fund Management S.a r.l. 66,743 5,141,992 7.74%
Sanofi 36,124 2,783,096 6.76%
Redmile Group, LLC 35,486 2,733,926 2.38%
Cormorant Asset Management, LP 32,000 2,465,348 1.64%
TCG Crossover Management, LLC 26,650 2,053,233 0.64%
FEDERATED HERMES, INC. 21,001 1,618,000 0.03%
Nantahala Capital Management, LLC 20,355 1,568,188 0.68%
Casdin Capital, LLC 20,119 1,550,000 1.01%
FMR LLC 18,933 1,458,677 0.0%
Andera Partners 17,079 1,538,702 9.72%
Aberdeen Group plc 10,990 846,695 0.02%
PERCEPTIVE ADVISORS LLC 7,788 600,000 0.12%
Samsara BioCapital, LLC 7,788 600,000 0.64%
Siren, L.L.C. 5,338 411,250 0.11%
ORBIMED ADVISORS LLC 2,501 192,740 0.05%
PFIZER INC 1,035 75,000 0.61%
ALPS ADVISORS INC 648 49,984 0.0%
Bellevue Group AG 639 49,248 0.01%
SEVEN GRAND MANAGERS, LLC 617 47,600 0.02%
SECTORAL ASSET MANAGEMENT INC 564 43,500 0.39%
Burkehill Global Management, LP 454 35,000 0.02%
Quadrature Capital Ltd 265 20,461 0.0%
Crossmark Global Holdings, Inc. 256 23,096 0.0%
TWO SIGMA INVESTMENTS, LP 234 18,072 0.0%
HRT FINANCIAL LP 221 17,075 0.0%